Paclitaxel-Loaded Nanobubble Targeted to Pro-Gastrin-Releasing Peptide Inhibits the Growth of Small Cell Lung Cancer

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s199175
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

New ARCHITECT Plasma Pro-Gastrin-Releasing Peptide Assay for Diagnosing and Monitoring Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2016English

Molecular Basis of the Selectivity of Gastrin-Releasing Peptide Receptor for Gastrin-Releasing Peptide

Molecular Pharmacology
Molecular MedicinePharmacology
2002English

Changes of Serum Pro-Gastrin-Releasing Peptide(proGRP) in Comparison With Neuron-Specific Enolase(NSE) During Induction Chemotherapy in Patients With Untreated Small Cell Lung Carcinoma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1995English

Gastrin-Releasing Peptide Receptor (GRPr) Promotes EMT, Growth, and Invasion in Canine Prostate Cancer

Prostate
OncologyUrology
2016English

Eribulin Inhibits the Growth of Small Cell Lung Cancer Cell Lines Alone and With Radiotherapy

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Glycine-Extended Gastrin Promotes the Growth of Lung Cancer

Cancer Research
Cancer ResearchOncology
2004English

Antagonists of Bombesin/Gastrin-Releasing Peptide as Adjuncts to Agonists of Luteinizing Hormone–releasing Hormone in the Treatment of Experimental Prostate Cancer

Cancer
Cancer ResearchOncology
1993English

Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
1999English

Antibody-Targeted Paclitaxel Loaded Nanoparticles for the Treatment of CD20+ B-Cell Lymphoma

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy